Share on LinkedInShare on LinkedIn

ARTICLE · 26 SEPTEMBER 2023

FTC Targets Private Equity In Challenge To Anesthesiology Roll-Ups

Duane Morris LLP
Duane Morris LLP
Contributor
Explore more from Duane Morris LLP

On September 21, 2023, the Federal Trade Commission (FTC) sued U.S. Anesthesia Partners Inc. (USAP) and Welsh, Carson, Anderson & Stowe XI L.P., among other private equity funds, in the United States District Court for the Southern District of Texas under the antitrust laws.

United StatesAntitrust/Competition Law

On September 21, 2023, the Federal Trade Commission (FTC) sued U.S. Anesthesia Partners Inc. (USAP) and Welsh, Carson, Anderson & Stowe XI L.P. (collectively, with other private equity fund defendants, "Welsh Carson"), among other private equity funds, in the United States District Court for the Southern District of Texas under the antitrust laws. Specifically, the FTC alleges that USAP and Welsh Carson engaged in an anti-competitive scheme to consolidate anesthesia practices in Texas and to force other independent anesthesia groups into price-setting arrangements that violated Section 2 of the Sherman Act, Section 7 of the Clayton Act and Section 5 of the FTC Act.

Key Takeaways

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Disclaimer: This Alert has been prepared and published for informational purposes only and is not offered, nor should be construed, as legal advice. For more information, please see the firm's full disclaimer.

See more popular content from